RedChip Companies
|
Weekly Newsletter
|
|
|
BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development
|
BullFrog AI (Nasdaq: BFRG), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, signed a three-year global strategic partnership with the Lieber Institute for Brain Development (LIBD), a non-profit research institute that maintains the world's largest repository of postmortem brains for the study of neuropsychiatric disorders. Under the terms of the agreement, BullFrog AI will leverage its bfLEAP™ platform to mine LIBD's comprehensive brain data, including transcriptomic, genomic, DNA methylation, cell-line, clinical, and imaging data. The goal of the partnership is to identify previously unrecognized relationships between genes and pathways in the brain and the development of neurologic and psychiatric disorders, thereby facilitating the development of more effective treatments for diseases of the human brain.
For more information, visit www.bullfrogai.com
|
Splash Beverage Group Signs Letter of Intent to Acquire Western Son Vodka
Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, today announced it has executed a Letter of Intent (“LOI”) to acquire JEM Beverage Management Company, LLC, owners of the brand Western Son Vodka. Western Son Vodka, founded in 2011 is headquartered in Pilot Point, Texas, with a production and distribution campus spanning more than 150,000 square feet. Over the last twelve months Western Son Vodka has sold approximately 309,000 9-liter cases of vodka. Distilled 10X and made with 100% American corn, the award-winning portfolio includes a Best-in-Class Original Vodka and is a four-time winner of Impact’s Spirits Hot Brand Award.
|
BioVie Presents Data Highlighting Baseline Characteristics of Study Population in Phase 3 Trial of NE3107 in Mild to Moderate Alzheimer’s Disease
BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that preliminary baseline data from its multicenter, randomized, placebo-controlled Phase 3 study (NCT04669028) of NE3107 in patients with mild to moderate Alzheimer’s Disease (AD) was presented as a poster at the American Neurological Association (ANA) annual meeting, held September 11-13, 2023 in Philadelphia, PA.
|
|
|
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses
Zomedica (NYSE American: ZOM), a veterinary health company offering diagnostic and therapeutic products for companion animals, announced the commercial launch of its newest assay - endogenous ACTH (eACTH) for equine plasma - for the TRUFORMA In-Clinic Biosensor Testing Platform. Larry Heaton, Zomedica's Chief Executive Officer, commented, “This assay enables equine veterinarians in the clinic or at the stall to diagnose equine Cushing's Disease, known clinically as pituitary pars intermedia dysfunction (PPID), and monitor positive patients as they titrate therapy. This new assay for the TRUFORMA instrument is an example of Zomedica's ongoing focus to meet the needs of clinical veterinarians in ways that promote both patient and practice health.”
|
Genius Group Announces that ERL is Approved to List on Upstream
Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, announced that its subsidiary Entrepreneur Resorts Ltd (“ERL”) has been approved to change its listing from the main board of MERJ Exchange to Upstream, a new MERJ Exchange market. ERL will commence trading on Upstream on September 25, 2023.
|
|
|
Small Stocks Big Money™ Podcasts
|
|
|
Upcoming Events |
|
|
|
NASDAQ: RVPH - Reviva Pharmaceuticals Holdings |
4:15pm Eastern |
Reviva is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. |
|
|
|
|
NYSE AMERICAN: SBEV - Splash Beverage Group |
4:15pm Eastern |
Splash Beverage Group is constantly innovating, presenting exciting, new, natural, and healthy drinks that delight the body and inspire the mind. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
11:00am Eastern |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
NASDAQ: SPI - SPI Energy |
4:15pm Eastern |
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
4:15pm Eastern |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
NASDAQ: DGLY - Digital Ally |
4:15pm Eastern |
Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. |
|
|
Archive Events |
|
|
|
NASDAQ: BFRG - BullFrog AI |
Meeting Duration 43 minutes |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
NASDAQ: BIVI - BioVie |
Meeting Duration 42 minutes |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 45 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: SXTP - Sixty Degrees Pharmaceuticals |
Meeting Duration 35 minutes |
60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. |
|
|
|
|
OTC: ARDS - Aridis Pharmaceuticals |
Meeting Duration 37 minutes |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: LTRN - Lantern Pharma |
Meeting Duration 14 minutes |
Lantern Pharma (NASDAQ: LTRN) is an AI company that aims to transform the cost, pace, and timeline of oncology drug discovery and development. |
|
|
|
|
NYSE American: ZOM - Zomedica |
Meeting Duration 46 minutes |
Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
Meeting Duration 41 minutes |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
Meeting Duration 28 minutes |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
NYSE American: GRFX - Graphex Group |
Meeting Duration 47 minutes |
Graphex Group is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. |
|
|
|
|
OTC: EBZT - Everything Blockchain |
Meeting Duration 35 minutes |
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. |
|
|
|
|
NASDAQ: SNGX - Soligenix |
Meeting Duration 48 minutes |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
OTCQB: QYOUF - QYOU Media |
Meeting Duration 46 minutes |
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
Lesson of the Week
Learn about value investing in this week's lesson.
|
|
|
MidSouth Week in Review
The Dollar hit 105 vs. 99 in July. U.S. small cap stocks have hit a 22-year low relative to large caps.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|